Showing results (231-240 of 1,338) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|January 12, 2024
A LINE-1 mediated deletion resulting in germline retinoblastoma predispositionErica L Macke, Anthony R Miller, Eileen Stonerock, et al.
Neuro-Oncology Advances|January 12, 2024
MGMT function determines the differential response of ATR inhibitors with DNA-damaging agents in glioma stem cells for GBM therapyVincent W S Leong, Sabbir Khan, Pratibha Sharma, et al.
Neuro-Oncology Advances|January 8, 2024
Wait-and-scan management in sporadic Koos grade 4 vestibular schwannomas: A longitudinal volumetric studySammy M Schouten, Stefan Cornelissen, Patrick P H J Langenhuizen, et al.
Neuro-Oncology Advances|January 10, 2024
Quantification of perineural satellitosis in pretreatment glioblastoma with structural MRI and a diffusion tensor imaging templateRik van den Elshout, Benthe Ariëns, Joost Blaauboer, et al.
Neuro-Oncology Advances|December 22, 2023
Analysis of treatment sequence and outcomes in patients with relapsed malignant peripheral nerve sheath tumorsLindy Zhang, Kathryn M Lemberg, Ana Calizo, et al.
Neuro-Oncology Advances|December 22, 2023
Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivityMaikel Verduin, Linde Hoosemans, Maxime Vanmechelen, et al.
Neuro-Oncology Advances|December 11, 2023
Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypesJared Stoller, Cymon N Kersch, Leslie L Muldoon, et al.
Neuro-Oncology Advances|November 29, 2023
Monitoring response to a clinically relevant IDH inhibitor in glioma-Hyperpolarized 13C magnetic resonance spectroscopy approachesDonghyun Hong, Yaewon Kim, Chandrasekhar Mushti, et al.
Neuro-Oncology Advances|November 29, 2023
A comparative study of microsurgery and gamma knife radiosurgery in vestibular schwannoma evaluating tumor control and functional outcomeMarcos Tatagiba, Sophie S Wang, Ahmed Rizk, et al.
Neuro-Oncology Advances|November 29, 2023
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphomaKarl-Heinz Nenning, Johanna Gesperger, Julia Furtner, et al.
Pageof 134